Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

Telmisartan for treatment of Covid-19 patients: An open multicenter randomized clinical trial

2021; Elsevier BV; Volume: 37; Linguagem: Inglês

10.1016/j.eclinm.2021.100962

ISSN

2589-5370

Autores

Mariano Duarte, Facundo Pelorosso, Liliana Nicolosi, María Victoria Salgado, Héctor Vetulli, Analía Aquieri, Francisco Azzato, Marcela Castro, Javier Coyle, Ignacio Dávolos, Ignacio Fernandez Criado, Rosana Gregori, Pedro Mastrodonato, María Cristina Rubio, Sergio Sarquís, Fernando Wahlmann, Rodolfo Pedro Rothlin,

Tópico(s)

Respiratory Support and Mechanisms

Resumo

Angiotensin receptor blockers (ARBs), such as telmisartan, have been postulated to treat Covid-19-induced lung inflammation.

Referência(s)